American National Insurance’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $728K | Sell |
12,250
-2,530
| -17% | -$162K | 0.2% | 152 |
|
|
2021
Q4 | $1.07M | Sell |
14,780
-80,915
| -85% | -$5.57M | 0.24% | 118 |
|
|
2021
Q3 | $6.68M | Sell |
95,695
-80
| -0.1% | -$5.62K | 0.25% | 109 |
|
|
2021
Q2 | $6.59M | Sell |
95,775
-140
| -0.1% | -$9.35K | 0.25% | 113 |
|
|
2021
Q1 | $6.2M | Sell |
95,915
-75
| -0.1% | -$4.84K | 0.25% | 115 |
|
|
2020
Q4 | $5.59M | Hold |
95,990
| – | – | 0.24% | 124 |
|
|
2020
Q3 | $6.07M | Hold |
95,990
| – | – | 0.29% | 99 |
|
|
2020
Q2 | $7.38M | Hold |
95,990
| – | – | 0.38% | 75 |
|
|
2020
Q1 | $7.18M | Hold |
95,990
| – | – | 0.46% | 66 |
|
|
2019
Q4 | $6.24M | Sell |
95,990
-7,175
| -7% | -$467K | 0.32% | 92 |
|
|
2019
Q3 | $6.54M | Hold |
103,165
| – | – | 0.35% | 90 |
|
|
2019
Q2 | $6.97M | Hold |
103,165
| – | – | 0.37% | 86 |
|
|
2019
Q1 | $6.71M | Hold |
103,165
| – | – | 0.35% | 95 |
|
|
2018
Q4 | $6.45M | Hold |
103,165
| – | – | 0.38% | 84 |
|
|
2018
Q3 | $7.96M | Hold |
103,165
| – | – | 0.39% | 74 |
|
|
2018
Q2 | $7.31M | Hold |
103,165
| – | – | 0.36% | 84 |
|
|
2018
Q1 | $7.78M | Hold |
103,165
| – | – | 0.4% | 77 |
|
|
2017
Q4 | $7.39M | Sell |
103,165
-89,710
| -47% | -$6.81M | 0.37% | 82 |
|
|
2017
Q3 | $15.6M | Sell |
192,875
-36,441
| -16% | -$2.79M | 0.82% | 29 |
|
|
2017
Q2 | $16.2M | Sell |
229,316
-3,100
| -1% | -$206K | 0.89% | 29 |
|
|
2017
Q1 | $15.8M | Hold |
232,416
| – | – | 0.88% | 28 |
|
|
2016
Q4 | $16.6M | Hold |
232,416
| – | – | 0.97% | 26 |
|
|
2016
Q3 | $18.4M | Hold |
232,416
| – | – | 1.07% | 17 |
|
|
2016
Q2 | $19.4M | Sell |
232,416
-11,509
| -5% | -$1.02M | 1.14% | 14 |
|
|
2016
Q1 | $22.4M | Sell |
243,925
-525
| -0.2% | -$47.3K | 1.33% | 9 |
|
|
2015
Q4 | $24.7M | Hold |
244,450
| – | – | 1.47% | 8 |
|
|
2015
Q3 | $24M | Hold |
244,450
| – | – | 1.53% | 5 |
|
|
2015
Q2 | $28.6M | Sell |
244,450
-16,475
| -6% | -$1.8M | 1.7% | 4 |
|
|
2015
Q1 | $25.6M | Hold |
260,925
| – | – | 1.51% | 6 |
|
|
2014
Q4 | $24.6M | Sell |
260,925
-4,600
| -2% | -$476K | 1.46% | 8 |
|
|
2014
Q3 | $28.3M | Hold |
265,525
| – | – | 1.72% | 5 |
|
|
2014
Q2 | $22M | Hold |
265,525
| – | – | 1.33% | 9 |
|
|
2014
Q1 | $18.8M | Hold |
265,525
| – | – | 1.2% | 11 |
|
|
2013
Q4 | $19.9M | Hold |
265,525
| – | – | 1.29% | 11 |
|
|
2013
Q3 | $16.7M | Hold |
265,525
| – | – | 1.19% | 12 |
|
|
2013
Q2 | $13.6M | Buy |
+265,525
| New | +$13.8M | 1.01% | 17 |
|
Other funds holding GILD
American National Insurance's GILD Position: Q1 2022 in Review
American National Insurance reduced its Gilead Sciences (GILD) stake by 17% in Q1 2022, selling an estimated $162K and leaving 12,250 shares worth $728K. The position accounts for 0.2% of the portfolio, ranked #152.
American National Insurance first reported a position in GILD in Q2 2013 and has held it in 36 quarters since. The position peaked at $28.6M in Q2 2015. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- American National Insurance held 12,250 shares of Gilead Sciences worth $728K as of Q1 2022.
- American National Insurance sold 2,530 Gilead Sciences shares in Q1 2022, an estimated $162K.
- Gilead Sciences made up 0.2% of American National Insurance's portfolio in Q1 2022, its #152 holding.
- American National Insurance first reported a position in Gilead Sciences in Q2 2013 and has held it in 36 quarters since.
- American National Insurance's Gilead Sciences position peaked at $28.6M in Q2 2015.
- 1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on American National Insurance's 13F filing for Q1 2022, filed 13 May 2022.